2026-04-18T04:28:50Zhttps://recercat.cat/oai/request

oai:recercat.cat:2445/1952312025-11-20T13:50:25Zcom_2072_1057col_2072_478799col_2072_478916col_2072_478917

00925njm 22002777a 4500 dc Pedrazza, Leonardo author Martinez-Martinez, Arturo author Sánchez de Diego, Cristina author Valer, José Antonio author Pimenta-Lopes, Carolina author Sala Gastón, Joan author Szpak, Michal author Tyler-Smith, Chris author Ventura Pujol, Francesc author Rosa López, José Luis author 2023-03-14T14:26:26Z 2023-03-14T14:26:26Z 2023-01-12 2023-03-14T14:26:26Z Bone remodeling is a continuous process between bone-forming osteoblasts and bone-resorbing osteoclasts, with any imbalance resulting in metabolic bone disease, including osteopenia. The HERC1 gene encodes an E3 ubiquitin ligase that affects cellular processes by regulating the ubiquitination of target proteins, such as C-RAF. Of interest, an association exists between biallelic pathogenic sequence variants in the HERC1 gene and the neurodevelopmental disorder MDFPMR syndrome (macrocephaly, dysmorphic facies, and psychomotor retardation). Most pathogenic variants cause loss of HERC1 function, and the affected individuals present with features related to altered bone homeostasis. Herc1-knockout mice offer an excellent model in which to study the role of HERC1 in bone remodeling and to understand its role in disease. In this study, we show that HERC1 regulates osteoblastogenesis and osteoclastogenesis, proving that its depletion increases gene expression of osteoblastic makers during the osteogenic differentiation of mesenchymal stem cells. During this process, HERC1 deficiency increases the levels of C-RAF and of phosphorylated ERK and p38. The Herc1-knockout adult mice developed imbalanced bone homeostasis that presented as osteopenia in both sexes of the adult mice. By contrast, only young female knockout mice had osteopenia and increased number of osteoclasts, with the changes associated with reductions in testosterone and dihydrotestosterone levels. Finally, osteocytes isolated from knockout mice showed a higher expression of osteocytic genes and an increase in the Rankl/Opg ratio, indicating a relevant cell-autonomous role of HERC1 when regulating the transcriptional program of bone formation. Overall, these findings present HERC1 as a modulator of bone homeostasis and highlight potential therapeutic targets for individuals affected by pathological HERC1 variants. Malalties dels ossos Diferenciació cel·lular Animals Ratolins (Animals de laboratori) Bone diseases Cell diferentiation Animals Mice (Laboratory animals) HERC1 deficiency causes osteopenia through transcriptional program dysregulation during bone remodeling